Clinical trial Recruiting at 1 site Interventional Ages 18 to 65

Monitoring postoperative pain after lumbar spine surgery using a heart-rate based pain index

Official title: Comparison Of Postoperative Analgesic Efficacy Using Analgesia Nociception Index Monitoring In Patients Undergoing Elective Lumbar Spine Surgery: A Randomized Parallel-Group Study

Run by Akdeniz University Hospital · NCT07455565 · Data updated 2026-11-12

This study tests whether an ultrasound-guided erector spinae plane block or intravenous multimodal pain medicines give better pain control for adults having elective lumbar spine surgery, using pain scores and the Analgesia Nociception Index.

Quick facts

Study typeInterventional
Ages18 Years to 65 Years
SexAll
Enrollment100 (estimated)
SponsorAkdeniz University Hospital
Academic / other
Locations1 site (Antalya, Antalya)
StatusRecruiting
StartedDecember 16, 2025
Main results expectedDecember 2026
Study endsDecember 2026
Registry record updatedMarch 6, 2026
Trial IDNCT07455565 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults aged 18–65 with ASA physical status I–II scheduled for elective lumbar spine surgery who can provide informed consent and have no contraindications to regional block or study medications are ideal candidates.

Probably not a fit

Patients with coagulation disorders, infection at the block site, severe cardiovascular disease, pregnancy, or inability to understand or follow the protocol are unlikely to benefit from participation.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This randomized parallel-group trial enrolls adults aged 18–65 undergoing elective lumbar spine surgery and assigns them to either bilateral ultrasound-guided erector spinae plane block (ESPB) or intravenous multimodal analgesia. Postoperative pain will be followed with serial Analgesia Nociception Index (ANI) measurements at predefined intervals up to 24 hours, alongside clinical Visual Analog Scale (VAS) scores, total opioid consumption in the first 24 hours, hemodynamic data, and adverse events. The primary outcome is a comparison of early postoperative ANI values between the two groups, with secondary outcomes including VAS scores, opioid requirements, and incidence of analgesia-related side effects. The protocol uses objective heart-rate variability monitoring together with standard clinical measures to determine which analgesic strategy provides better early postoperative pain control.

Why it matters

Potential benefit: If successful, the preferred approach could reduce postoperative pain and opioid use after lumbar spine surgery, improving patient comfort and recovery.

How similar studies have gone: Prior smaller studies have reported that ESPB can reduce postoperative pain and ANI can provide objective nociception data, but randomized comparisons against standardized IV multimodal regimens remain limited.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Age between 18 and 65 years
* ASA physical status I-II
* Scheduled for elective lumbar spine surgery
* Ability to provide informed consent

Exclusion Criteria:

* Known allergy to study medications
* Coagulation disorders
* Infection at the block site
* Severe cardiovascular disease
* Pregnancy
* Inability to understand the study protocol

Where it's running

  • Akdeniz University Faculty of Medicine Hospital
    Antalya, Antalya, Turkey (Türkiye)
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.